Deprescribing in older people receiving palliative care in hospice
Research type
Research Study
Full title
Attitudes of patients, carers and healthcare professionals towards deprescribing in older people receiving palliative care in hospice settings
IRAS ID
290526
Contact name
Carole Parsons
Contact email
Sponsor organisation
Queen's University Belfast
Duration of Study in the UK
0 years, 3 months, 0 days
Research summary
The study will involve a distribution of questionnaire surveys (online and paper-based) to patients, carers, and healthcare professionals (HCPs) including doctors, nurses and pharmacists who are involved with palliative care services in hospice settings. The primary goal of this study is to assess the attitudes of patients, carers and HCPs towards deprescribing in older people with limited life expectancy (LLE) due to life-limiting illness (LLI) who are receiving palliative care services provided by a hospice in the United Kingdom (UK). Deprescribing is the planned process of dose reduction or stopping of medicines that might be causing harm, or no longer be of benefit, supervised by a healthcare professional. Data will be collected through the use of online or paper questionnaires. Patients and carers will be recruited through four organisations in the UK: Marie Curie Hospice, Sue Ryder Hospice, Northern Ireland (NI) Hospice and the All-Ireland Institute of Hospice and Palliative Care (AIIHPC). HCPs will be recruited through three organisations: Marie Curie Hospice, Sue Ryder Hospice, and NI Hospice. The collected data from all participants will include demographic information and participants' responses which best reflect the extent to which they agree or disagree with a number of statements about deprescribing.
REC name
HSC REC A
REC reference
21/NI/0037
Date of REC Opinion
11 Mar 2021
REC opinion
Further Information Favourable Opinion